Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder
4/26/2012 7:28:32 AM
More...
|
Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Positive Phase III Results For Levomilnacipran in Patients With Major Depressive Disorder
3/7/2012 7:28:59 AM
More...
|
Pierre Fabre Medicament is Granted Authorization in Australia to Market the Milnacipran JONCIA(R) to Treat Fibromyalgia
11/21/2011 11:56:20 AM
More...
|
Forest Laboratories, Inc. (FRX), Pierre Fabre Medicament Announce Positive Phase III Results with Levomilnacipran in Patients with Major Depressive Disorder
7/18/2011 6:32:52 AM
More...
|
Pierre Fabre Medicament And Zambon Sign Commercial Agreement In Germany
2/21/2007 5:14:34 PM
More...
|
Novacea And Pierre Fabre Medicament Enter Into Partnership For The Development And Commercialization Of Oral Vinorelbine For Oncology
10/19/2005 5:12:09 PM
More...
|
Pierre Fabre Medicament And Merck & Co. (MRK) Sign Oncology Research Partnership And Licensing Agreement
10/19/2005 5:11:19 PM
More...
|
Bristol-Myers Squibb Company (BMY) And Pierre Fabre Medicament Enter Into Agreement To Develop And Commercialize Oncology Treatment Javlor(R) (vinflunine)
10/19/2005 5:10:57 PM
More...
|
Cypress Bioscience Inc., (CYPB) Forest Laboratories, Inc. (FRX) And Pierre Fabre Medicament Announce Development And Marketing Agreement For Milnacipran
10/19/2005 5:09:39 PM
More...
|